Hindenburg Research said on Tuesday it has a short position in activist investor Carl Icahn-controlled energy-to-pharma conglomerate Icahn Enterprises <a href="https://www.reuters.com/companies/IEP.O" target="_blank">(IEP.O)</a>, making it the latest in a str…